Stable fixed-dose formulations containing a combination of antivirals, method for producing thereof using dry granulation

Details for Australian Patent Application No. 2006257794 (hide)

Owner Gilead Sciences, Inc.

Inventors Yang, Taiyin; Oliyai, Reza; Menning, Mark M.; Dahl, Terrence C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006257794

PCT Pub. Number WO2006/135932

Priority 60/771,353 07.02.06 US; 60/690,010 13.06.05 US

Filing date 13 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 24 June 2010

International Classifications

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135932 Priority application(s): WO2006/135932

24 June 2010 Application Accepted

  Published as AU-B-2006257794

21 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257795-Stable fixed-dose unitary formulations containing tenofovir, a surfactant, efavirenz and emtricitabine

2006257792-Transmucosal delivery of peptide derivatives